This photo shows the GlaxoSmithKline offices in London. GlaxoSmithKline LLC will pay $3 billion and plead guilty to promoting two popular drugs for unapproved uses and to failing to disclose important safety information in the largest health care fraud settlement in U.S. history.

First published in the July 02, 2012, 4:48 p.m. edition

Go to the DailySource front page